Detox Centers Face Death Lawsuits Over Oversight

Concerns are mounting over patient safety within the addiction treatment industry, particularly at detox and residential centers, following a series of patient deaths. Families are filing wrongful death lawsuits, alleging that the promised 24/7 medical supervision was inadequate during the fragile hours of withdrawal. This issue is amplified as investor money, including private equity, increasingly flows into these facilities, altering their ownership landscape.

The addiction treatment market, valued at over $42 billion, has seen significant expansion since federal laws in 2008 and 2010 mandated insurance coverage for substance use disorders. This influx of revenue attracted corporate buyers and outside investors. However, oversight for these facilities varies by state, and licensing and accreditation processes do not always guarantee consistent medical supervision, especially with staffing shortages.

Recent legal filings detail disturbing cases, including a 21-year-old's death from an overdose after alleged drug provision by staff, a man who died due to lack of monitoring for over nine hours, and another who suffered a cardiac event without vital-sign monitoring. A separate incident involved a patient with a documented peanut allergy who was served peanuts, leading to anaphylactic shock and death.

These tragedies underscore a critical disconnect between the advertised level of care and the reality experienced by vulnerable patients. The per-day reimbursement model and the drive to maintain full beds can create financial pressures that potentially influence patient care decisions. Patient advocates are calling for greater transparency regarding safety incidents, staffing, and ownership structures.